31/07/2026
At the Vitiligo Society of Kenya (VISOKE), we believe that evidence-based medicine should guide the future of vitiligo care. We support safe, scientifically validated therapies that help people with vitiligo achieve their treatment goals, including repigmentation where appropriate. Together, let's advance research, hope, and better patient outcomes. 💜
CLINUVEL PHARMACEUTICALS LTD
When looking for a treatment for vitiligo, 67% of patients report that repigmentation is the main treatment goal, with over 42% wanting a treatment they can use long-term.
Current therapies that fulfill both goals are limited. CLINUVEL is working to change that and to give those who seek treatment more effective options.
Read more about our ongoing vitiligo program here: https://www.clinuvel.com/pharmaceuticals/disease-entities/vitiligo/
---
Source: Rosmarin, D., H. Lofland, J., Marwaha, S., Piercy, J., Anderson, P., & Liu, J. (2024). Patient burden of nonsegmental vitiligo: A US Real-World survey of dermatologists and their patients. Dermatology and Therapy. https://link.springer.com/article/10.1007/s13555-024-01165-5
